Reduces the load on the heart and widens the coronary arteries
Controlled release form works through the day for prevention
Manufactured at a WHO-GMP certified facility under GLP and ISO norms
Every batch quality tested in-house before dispatch
Indications of Glystat-2.6
Chronic stable angina
Angina prophylaxis
Coronary artery disease
How Glystat-2.6 works
Nitroglycerine is converted in the vessel wall to nitric oxide, which relaxes smooth muscle. Its main effect is on the veins: less blood returns to the heart, so the heart is less stretched and needs less oxygen. It also widens the coronary arteries themselves. The controlled-release form is for preventing angina through the day rather than stopping an attack in progress.
Why ChooseGlystat-2.6?
Manufactured at a WHO-GMP certified facility under GLP, ISO and GMP norms, with raw material from approved vendors and in-house quality testing on every batch. Cardiac medicines are taken every day for years, so batch-to-batch consistency is not a formality here -- it is what keeps a stable patient stable. Offered to PCD franchise partners on district-wise monopoly rights, with pan-India supply and complete promotional support.
Frequently asked questions about Glystat-2.6
Is monopoly available for this product?
Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.
What is the composition of Glystat-2.6?
Nitroglycerine controlled release 2.6 mg.
Is this manufactured at a WHO-GMP certified facility?
Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is quality tested in-house before dispatch.
What is the minimum order quantity?
Please contact our team for the current MOQ and price structure for your territory.
Last updated on 29 August 2026
This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.
Cista Medicorp
